TrialPloS one2023

Integrated analysis of phase 1a and 1b randomized controlled trials; Treg-targeted cancer immunotherapy with the humanized anti-CCR4 antibody, KW-0761, for advanced solid tumors.

Kaoru Fujikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.